169 related articles for article (PubMed ID: 35640730)
1. The mevalonate pathway in breast cancer biology.
Göbel A; Riffel RM; Hofbauer LC; Rachner TD
Cancer Lett; 2022 Aug; 542():215761. PubMed ID: 35640730
[TBL] [Abstract][Full Text] [Related]
2. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
4. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
6. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
Ahmadi Y; Ghorbanihaghjo A; Argani H
Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
[TBL] [Abstract][Full Text] [Related]
7. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
Muller AL; Freed DH
Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
[TBL] [Abstract][Full Text] [Related]
8. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
[TBL] [Abstract][Full Text] [Related]
10. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
11. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Mevalonate Pathway for Treating Esophageal Cancer.
Wong JVS; Fatehi Hassanabad A
J Gastrointest Cancer; 2021 Jun; 52(2):819-821. PubMed ID: 33931828
[TBL] [Abstract][Full Text] [Related]
13. p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.
Centonze G; Natalini D; Grasso S; Morellato A; Salemme V; Piccolantonio A; D'Attanasio G; Savino A; Bianciotto OT; Fragomeni M; Scavuzzo A; Poncina M; Nigrelli F; De Gregorio M; Poli V; Arina P; Taverna D; Kopecka J; Dupont S; Turco E; Riganti C; Defilippi P
Cell Death Dis; 2023 Dec; 14(12):849. PubMed ID: 38123597
[TBL] [Abstract][Full Text] [Related]
14. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
[TBL] [Abstract][Full Text] [Related]
15. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
[TBL] [Abstract][Full Text] [Related]
16. The Mevalonate Pathway and Innate Immune Hyper-Responsiveness in the Pathogenesis of COPD and Lung Cancer: Potential for Chemoprevention.
Young RP; Hopkins RJ
Curr Mol Pharmacol; 2017; 10(1):46-59. PubMed ID: 26758944
[TBL] [Abstract][Full Text] [Related]
17. Statins: perspectives in cancer therapeutics.
Corcos L; Le Jossic-Corcos C
Dig Liver Dis; 2013 Oct; 45(10):795-802. PubMed ID: 23490341
[TBL] [Abstract][Full Text] [Related]
18. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets.
Proto MC; Fiore D; Piscopo C; Pagano C; Galgani M; Bruzzaniti S; Laezza C; Gazzerro P; Bifulco M
Prog Lipid Res; 2021 Apr; 82():101099. PubMed ID: 33915202
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
[TBL] [Abstract][Full Text] [Related]
20. Metabolic control of YAP and TAZ by the mevalonate pathway.
Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
